ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1367	National Cancer Institute	Html	en	Skin Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for skin cancer.	commonly occurring cancer 0.623357 skin cancer 0.936474 pediatric melanoma 0.671304 SCREEN study population 0.580579 skin awareness 0.580742 melanoma incidence rates 0.734128 observed modest mortality 0.599763 squamous cell cancers 0.595008 average annual incidence 0.632599 reduces melanoma mortality. 0.659883 health outcomes 0.587808 American Cancer Society 0.618195 important methodological limitations 0.577191 skin biopsy rates 0.677147 direct evidence 0.584321 nearly one-half 0.583908 two-stage skin cancer 0.6325 Medicare fee-for-service data 0.592604 U.S. cancer registries 0.618554 skin cancer screening 0.7411 melanoma 0.802792 UV radiation 0.57829 skin cancer awareness 0.703316 total-body visual examination 0.577539 vertical growth phase 0.58165	melanoma mortality rates 0.760008 reportable cancer 0.578136 End Results Program 0.589373 internal control group 0.578284 Basal cell carcinoma 0.600196 United States 0.662165 population-based skin cancer 0.635467 prolonged horizontal growth 0.582398 yearly incidence increase 0.63333 nonmelanoma skin cancers 0.683707 skin cancer. 0.5773 National Cancer Institute 0.614591 total number 0.59851 horizontal growth phase 0.661114 U.S. incidence rates 0.65648 main types 0.601467 initial pilot phase 0.579738 local disease 0.593927 skin lesions 0.583166 individual’s skin 0.577585 fewer melanoma death 0.654325 nonmelanoma skin cancer 0.723959 clinical visual screening 0.595993 SCREEN study 0.606378	CLICK HERE
1400	National Cancer Institute	Html	en	Pruritus (PDQ®)–Patient Version	Expert-reviewed information summary about pruritus (itching of the skin) as a complication of cancer or its treatment. Approaches to the management and treatment of pruritus are discussed.	pruritus 0.90328 cancer treatment 0.548786 pruritus triggers 0.621529 itchy area 0.539512 PDQ cancer information 0.801119 sensitive skin 0.546664 clinical trials 0.578 slightly warm water 0.581894 skin irritation 0.524209 cancer information summary 0.687111 clinical trial 0.527617 breast cancer prevention 0.527738 allergic skin reactions 0.565555 PDQ summaries 0.536776 NCI’s PDQ 0.543089 NCI PDQ cancer 0.611108 abnormally dry skin 0.57148 radiation therapy 0.699633 mild skin cleansers 0.572586 healthy skin 0.527165 dry skin 0.774485 severe pruritus 0.605619 treatment 0.566915 skin reactions 0.571172	cancer prevention 0.529379 skin 0.938312 fabric softener 0.603284 Cancer Information Service 0.550768 PDQ Supportive 0.525373 Skin care 0.536556 treatment clinical trials 0.52545 National Cancer Institute 0.683212 PDQ documents 0.525692 pruritus feels 0.65464 Palliative Care Editorial 0.58903 new treatment 0.528187 Long-term dry skin 0.58669 Cancer Care page 0.536284 PDQ database 0.530553 Care Editorial Board 0.591687 skin stay 0.527676 PDQ summary 0.56881 skin biopsy 0.53042 sedimentation rate 0.58564 skin cells 0.531813 skin lesions 0.545694 cancer information summaries 0.561413 comprehensive cancer information 0.556845	CLICK HERE
1573	National Cancer Institute	Html	en	Paranasal Sinus and Nasal Cavity Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of paranasal sinus and nasal cavity cancer.	clinical trial 0.388177 treatment 0.382326 nasal cavity cancer 0.775733 nasal cavity 0.985485	radiation therapy 0.64284 cancer 0.858763 paranasal sinus 0.474859 clinical trials 0.346263	CLICK HERE
1739	National Cancer Institute	Html	en	Paget Disease of the Breast	A fact sheet about Paget disease of the breast, a rare type of cancer that is sometimes called Paget disease of the nipple or mammary Paget disease.	widely accepted theory 0.431005 Paget disease 0.968679 lymph node dissection 0.448538 breast travel 0.50595 Female Breast 0.492116 benign skin conditions 0.467839 invasive cancer 0.46682 Breast Cancer Research 0.515399 nearby lymph nodes 0.47834 5-year relative survival 0.483297 circular cutting tool 0.430646 lymph node biopsy 0.495901 sentinel lymph node 0.515084 areola 0.440286 entire nipple 0.437315 additional diagnostic tests 0.431017 Paget cells 0.564932 breast tumor 0.509157 lymph nodes 0.480504 nipple biopsy 0.469807 lymph node surgery 0.448775 invasive breast cancer 0.541802 breast lump 0.501651 extramammary Paget disease 0.567848 magnetic resonance imaging 0.430693	cancer cells 0.444445 breast cancer recurrence 0.516664 benign skin condition 0.434676 National Cancer Institute 0.437477 tumor cells 0.436713 early symptoms 0.436544 rare type 0.434028 breast changes 0.501251 breast tumors 0.519719 British doctor Sir 0.43376 Breast Journal 0.497022 clinical breast exam 0.531889 breast cancer 0.589051 HER2 protein overexpression 0.430335 Sir James Paget 0.592188 people 0.452202 breast cancer treatments 0.51665 lymph node involvement 0.446932 darker circle 0.435564 axillary lymph node 0.477668 mammary Paget disease 0.579396 et al 0.471939 breast 0.816594 Surgical Oncology 0.430364	CLICK HERE
1920	National Cancer Institute	Html	es	Tratamiento del cáncer de vejiga (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de vejiga.	pequeño bucle 0.447801 siguientes procedimientos 0.673413 Schistosoma haematobium 0.482783 cistectomía segmentaria 0.460288 estadio iv 0.822603 cáncer.ampliar cistoscopia 0.483661 pequeña cantidad 0.462732 estadio ii 0.569624 túbulos renales 0.485429 siguientes tipos 0.465952 rayos x 0.462117 sistema urinario masculino 0.534793 enlace drugs approved 0.625136 células t 0.506117 posibles signos 0.638701 National Cancer Institute 0.427365	pelvis renal 0.667965 Instituto Nacional 0.454933 PDQ Tratamiento 0.458142 antecedentes familiares 0.468632 Physician Data Query 0.515351 Bladder Cancer 0.523198 estadio iii 0.506874 siguientes situaciones 0.472048 vejiga almacena 0.929353 pequeños hongos 0.45501 panel derecho 0.577787 células renales 0.591906 siguientes sumarios 0.537471 siguientes pruebas 0.493409 siguientes estadios 0.478175	CLICK HERE
1997	National Cancer Institute	Html	es	Tratamiento de los astrocitomas infantiles (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los astrocitomas infantiles.	high-grade astrocytoma 0.444609 BRAF mutation 0.44863 pontine gliomas 0.513199 brain tumors 0.449797 cerebellar astrocytomas 0.465185 astrocitomas pilocíticos 0.812488 Cancer Res 0.478751 thalamic gliomas from 0.475546 neurofibromatosis tipo 0.470126 pilocytic astrocytoma 0.928999 Children's Oncology Group 0.451226 optic-hypothalamic gliomas 0.471792 central nervous system 0.495263 gliomas reveals key 0.471536 h3f3a k27m mutation 0.438972 Nat Genet 0.454568 pediatric gliomas 0.555458 astrocitomas difusos).Recién 0.471123 Glioma Treated with 0.441082 Acta Neuropathol 0.692887 Pediatric Pilocytic Astrocytomas 0.43879 mutación braf v600e 0.473181 Organización Mundial 0.468352 Salud Grado 0.453036 Metastatic Low-Grade Gliomas 0.479197	braf v600e mutation 0.454684 astrocitomas infantiles grupo 0.489856 vía óptica 0.453436 Neuro Oncol 0.501948 BRAF V600E 0.638339 low-grade glioma 0.976552 Pediatr Blood Cancer 0.686119 gliomas with braf 0.498818 low-grade astrocytomas 0.452781 fusión braf-kiaa1549 0.457715 childhood low-grade glioma 0.438409 optic pathway glioma 0.455238 mutaciones braf v600e 0.497547 diffuse high-grade astrocytomas 0.440868 malignant gliomas arising 0.476149 Clin Oncol 0.452652 nervous system tumors 0.44069 sistema nervioso central 0.547399 gliomas identifies recurrent 0.476033 mutaciones braf 0.520493 mutaciones puntuales braf 0.489841 Saluda Tipo Grado 0.458304 presuntos gliomas 0.491024 Neuropathol Exp Neurol 0.51285	CLICK HERE
2005	National Cancer Institute	Html	es	Tratamiento de los tumores de estroma gastrointestinal (PDQ®)–Versión para pacientes	Información revisada por expertos sobre el tratamiento de los tumores de estroma gastrointestinal.	pequeñas incisiones 0.627953 siguientes procedimientos 0.660138 cuidado médico 0.818499 tubo gi.ampliar 0.664881 siguientes aspectos 0.645973 Neurofibromatosis tipo 0.638907 siguientes síndromes 0.651683 rayos x 0.707199 enlace drugs approved 0.645052 escáner tep 0.637347 ondas sonoras 0.640024 National Cancer Institute 0.620652 causarán signos 0.637878	siguientes riesgos 0.61572 Instituto Nacional 0.681879 PDQ Tratamiento 0.652674 siguientes problemas 0.648983 tubo gi 0.979564 Physician Data Query 0.683259 tumor mide 0.671706 PDQ Cánceres 0.69873 siguientes enlaces 0.62151 siguientes órganos 0.656962 siguientes pruebas 0.650191 Gastrointestinal Stromal Tumors 0.704979	CLICK HERE
3769	National Cancer Institute	Html	es	Medicina de precisión en el tratamiento del cáncer	Información sobre el papel que tiene la medicina de precisión en el tratamiento del cáncer.	precisión para tratamiento 0.796037 máquina llamada secuenciador 0.682468 cuáles cambios 0.881741 cuáles tratamientos funcionarán 0.880419 que los pacientes 0.633734	campo de investigación 0.604701 seguro médico 0.550546 cáncer el cambio 0.9829 responda el tumor 0.621072 a cuáles tratamientos 0.724195	CLICK HERE
16247	National Cancer Institute	Html	en	Examining the Effects of Presurgical Treatment for Prostate Cancer	In this study, men diagnosed with androgen-sensitive prostate cancer with intermediate- or high-risk features will be examined with mpMRI, undergo targeted biopsies, and be treated with neoadjuvant androgen deprivation therapy.	prostate tumors 0.614738 mpMRI scans 0.310993 new strategies 0.267582 potential tumor markers 0.311786 clinical trials 0.372782 targeted biopsy samples 0.322875 targeted lesions 0.294339 specific prostate lesions 0.476878 high-risk features 0.288054 newly diagnosed prostate 0.622232 metastatic prostate cancer 0.498919 prostate cancer cells 0.594259 surgically removed organs 0.312098 antiandrogen drug enzalutamide 0.322935 single imaging exam 0.312805 Dr. William Dahut 0.330786 systemic therapy 0.28819 neoadjuvant therapy 0.769289 aggressive prostate cancers 0.483417 protocol summary 0.275419 androgen-deprivation therapy 0.285401 NCI Center 0.275353 magnetic resonance imaging 0.315153 trial contact information 0.309223 United States 0.272406	intensive hormonal therapy 0.397524 high-risk prostate tumors 0.477739 prostatectomy specimens 0.282563 Treating Patients 0.272894 initial mpMRI scans 0.308885 high-risk prostate cancer 0.602491 radical prostatectomy 0.351855 NCI Clinical Trials 0.312784 common malignancy 0.274438 androgen-sensitive prostate cancer 0.480836 potential strategy 0.266185 Cancer Research 0.343151 anatomic imaging 0.268037 drug goserelin actetate 0.309432 targeted biopsies 0.292493 male sex hormones 0.320468 Goserelin Acetate 0.270879 high-risk disease 0.33068 prostate cancer 0.95691 neoadjuvant ADT 0.340784 aggressive disease 0.267926 prostate cancer recurrence 0.502931 specific lesions 0.287557 effective neoadjuvant therapy 0.348548	CLICK HERE
17173	National Cancer Institute	Html	es	Hongos medicinales (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso de los hongos medicinales como tratamiento para las personas con cáncer.	adjuvant immunochemotherapy with 0.310705 ganoderma lucidum 0.95261 Coriolus versicolor 0.338242 Ganoderma lucidum from 0.330019 triterpenoids from ganoderma 0.34341 from ganoderma spp 0.316446 extracted from ganoderma 0.316294 Se-enriched Ganoderma lucidum 0.325078 mushroom ganoderma lucidum 0.326878 cuáles pacientes 0.311657 adjuvant immunochemotherapy 0.310969 cells with immuno-stimulatory 0.308341 PSK may 0.326201 polysaccharides from ganoderma 0.316147 Ganoderma lucidum induces 0.347342 Oncol Rep 0.321721 Ganoderma lucidum polysaccharides 0.378912 Ganoderma lucidum mycelia 0.327066 pacientes supervivencia 0.312919 Ganoderma polysaccharides with 0.315786 patients with 0.347196 protein-bound polysaccharide psk 0.327993 lz-8 from ganoderma 0.316148 Ganoderma lucidum activities 0.328306 metabolites from ganoderma 0.315749	ganoderma lingzhi wu 0.315644 PSK quizás 0.327997 Ganoderma lucidum spores-induced 0.32738 from ganoderma lucidum 0.482816 oficiales ganoderma lucidum 0.327352 immunochemotherapy with psk 0.347115 PSK therapies 0.324706 isolated from ganoderma 0.330138 commercial ganoderma 0.31277 lucidum suppresses angiogenesis 0.315879 Ganoderma based 0.312698 ganoderma sinense zhao 0.315248 Mol Med 0.308288 gastric cancer 0.374999 extract from ganoderma 0.316948 immunochemotherapy with polysaccharide 0.311361 breast cancer 0.314008 Mushroom Science 0.307833 Ganoderma lingzhi from 0.316096 ganoderma lucidum triterpenoids 0.328168 PSK potencia 0.327619 Ganoderma lingzhi 0.323758 leukemia cells 0.314028 estudios cáncer 0.308153	CLICK HERE